Molecular conjugates comprising human monoclonal antibodies to dendritic cells
US7560534B2 · kind B2 · utility
20Cited by
11References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 7, 2001 |
| Grant date | Jul 14, 2009 |
| Priority date | — |
| Expiry date | Apr 27, 2022 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/55
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Molecular conjugates comprising an antigen linked to a human monoclonal antibody that specifically binds to dendritic cells are disclosed. Also disclosed are pharmaceutical compositions comprising the molecular conjugates and therapeutic methods for using the conjugates.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.